Multi-omics Services for Dynamic Biomarkers

See why Sapient is preferred among multi-omics companies for large-scale metabolomics and proteomics studies exploring the dynamic factors modulating disease and drug response.

Unique among multi-omics companies – see how.

While the vast majority of biomarker discovery to date has focused on genomics, >80% of disease risk stems from non-genetic factors and exposures over time. This molecular landscape has remained largely unexplored, until now.

Sapient’s innovative technologies finally enable rapid, large-scale multi-omics biomarker discovery beyond the genome.

 We comprehensively profile metabolite, lipid, and protein biomarkers, which read out dynamic factors influencing health and disease – measuring thousands of biomarkers per sample, across thousands of samples at a time.

Discovery Metabolomics & Lipidomics

Capturing >15K small molecule biomarkers per biosample, including metabolites and lipids, with capacity to handle >5,000 samples per day.

Discovery Proteomics

Optimized approaches for interrogation of the plasma and tissue proteome, with our /Core/ Discovery method measuring 4,000+ proteins and PTMs in plasma.

Supported by an advanced biocomputational framework for analysis of multi-omics datasets, we deliver actionable insights to elucidate disease mechanisms, subtype diseases, and ultimately improve the precision and efficacy of therapies.

Download the Fact Sheet

Explore our integrative services for rapid multi-omics data generation & analysis and how they deliver unique value to accelerate your studies.

"*" indicates required fields


Ready to discover more?

Connect with our scientists to discuss our multi-omics services or the biological questions you want to answer. We’re here to help you gain actionable insight at any phase of development.